Literature DB >> 1722139

Search for the critical characteristics of phenotypically different B cell lines, Burkitt lymphoma cells and lymphoblastoid cell lines, which determine differences in their functional interaction with allogeneic lymphocytes.

J Avila-Cariño1, S Torsteinsdottir, B Ehlin-Henriksson, M G Masucci, E Klein.   

Abstract

Burkitt lymphoma (BL) lines can be grouped according to phenotypic characteristics. Group I cells exhibit the phenotype of resting B cells and grow as single cells. Such lines can be Epstein-Barr-virus(EBV)-negative or -positive. Group II and group III cells are always EBV-positive, they express B cell activation markers, grow in aggregates and resemble in varying degrees lymphoblastoid cell lines (LCL). We studied three groups of BL lines for their capacity to interact with allogeneic lymphocytes. The results showed that as long as the lines have the group I phenotype, they do not stimulate allogeneic T lymphocytes irrespective whether they carry the EBV genome. The group II and III cells are stimulatory. Generally there was no correlation between sensitivity ot lymphocyte-mediated lysis and the phenotype of the lines. In one set of lines, the group I cells had higher sensitivity to both natural killer and lymphokine-activated killer effectors compared to the group II or III lines. However, such correlation could not be seen with the other two sets of lines. Among the phenotypic features investigated, expression of the adhesion molecules LFA-1 and LFA-3 correlated with the tendency for cell aggregation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1722139     DOI: 10.1007/bf01741347

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  19 in total

Review 1.  In search of the 'missing self': MHC molecules and NK cell recognition.

Authors:  H G Ljunggren; K Kärre
Journal:  Immunol Today       Date:  1990-07

2.  Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.

Authors:  C D Gregory; M Rowe; A B Rickinson
Journal:  J Gen Virol       Date:  1990-07       Impact factor: 3.891

3.  Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.

Authors:  M G Masucci; S Torsteindottir; J Colombani; C Brautbar; E Klein; G Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

4.  Paired Epstein-Barr virus (EBV)-negative and EBV-converted Burkitt lymphoma lines: stimulatory capacity in allogeneic mixed lymphocyte cultures.

Authors:  J Avila-Cariño; S Torsteinsdottir; B Ehlin-Henriksson; G Lenoir; G Klein; E Klein; M G Masucci
Journal:  Int J Cancer       Date:  1987-11-15       Impact factor: 7.396

Review 5.  Leucocyte adhesion to cells. Molecular basis, physiological relevance, and abnormalities.

Authors:  M Patarroyo; M W Makgoba
Journal:  Scand J Immunol       Date:  1989-08       Impact factor: 3.487

6.  Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype.

Authors:  C D Gregory; T Tursz; C F Edwards; C Tetaud; M Talbot; B Caillou; A B Rickinson; M Lipinski
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

7.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

8.  Density separation of chronic lymphocytic leukemia cells: low-density non-T cells are efficient stimulator cells in allogeneic and autologous mixed leukocyte reaction.

Authors:  D Kabelitz; L Klareskog; B Simonsson
Journal:  Clin Immunol Immunopathol       Date:  1983-02

9.  Heritable lymphocyte function-associated antigen-1 deficiency: abnormalities of cytotoxicity and proliferation associated with abnormal expression of LFA-1.

Authors:  A M Krensky; S J Mentzer; C Clayberger; D C Anderson; F C Schmalstieg; S J Burakoff; T A Springer
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

10.  Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro.

Authors:  D J Moss; L E Wallace; A B Rickinson; M A Epstein
Journal:  Eur J Immunol       Date:  1981-09       Impact factor: 5.532

View more
  4 in total

1.  Morphologic and immunophenotypic characterization of a cell line derived from liver tissue with Epstein-Barr virus associated post-transplant lymphoproliferative disease.

Authors:  P S Randhawa; A Zeevi; C Alvares; S Gollin; R Agostini; E Yunis; S Saidman; L Contis; A J Demetris; M A Nalesnik
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-06       Impact factor: 2.416

2.  Characterization of B-cell lines from SLE patients and their relatives.

Authors:  T Witte; K Hartung; F M Bode; R E Schmidt; H Deicher
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

3.  Comparison of integrin adhesion molecules expressed by primary brain lymphomas and nodal lymphomas.

Authors:  W Paulus; K Jellinger
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

4.  In vitro culture of B-lymphocytes derived from Epstein-Barr-virus-associated posttransplant lymphoproliferative disease: cytokine production and effect of interferon-alpha.

Authors:  P Randhawa; T Whiteside; A Zeevi; M Nalesnik; C Alvares; S M Gollin; J Demetris; J Locker
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997 Nov-Dec       Impact factor: 2.723

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.